Marta Gwinn

Author PubWeight™ 114.18‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 The continuum of translation research in genomic medicine: how can we accelerate the appropriate integration of human genome discoveries into health care and disease prevention? Genet Med 2007 9.48
2 A navigator for human genome epidemiology. Nat Genet 2008 5.07
3 Sodium and potassium intake and mortality among US adults: prospective data from the Third National Health and Nutrition Examination Survey. Arch Intern Med 2011 4.22
4 The emergence of translational epidemiology: from scientific discovery to population health impact. Am J Epidemiol 2010 4.04
5 Can family history be used as a tool for public health and preventive medicine? Genet Med 2002 3.76
6 A critical appraisal of the scientific basis of commercial genomic profiles used to assess health risks and personalize health interventions. Am J Hum Genet 2008 3.25
7 Genetic test evaluation: information needs of clinicians, policy makers, and the public. Am J Epidemiol 2002 3.23
8 A road map for efficient and reliable human genome epidemiology. Nat Genet 2006 3.21
9 The Scientific Foundation for personal genomics: recommendations from a National Institutes of Health-Centers for Disease Control and Prevention multidisciplinary workshop. Genet Med 2009 2.91
10 On the synthesis and interpretation of consistent but weak gene-disease associations in the era of genome-wide association studies. Int J Epidemiol 2006 2.66
11 Strengthening the reporting of genetic association studies (STREGA): an extension of the strengthening the reporting of observational studies in epidemiology (STROBE) statement. J Clin Epidemiol 2009 2.45
12 STrengthening the REporting of Genetic Association Studies (STREGA): an extension of the STROBE statement. PLoS Med 2009 2.39
13 Tracking the epidemiology of human genes in the literature: the HuGE Published Literature database. Am J Epidemiol 2006 2.34
14 Genome-wide association studies, field synopses, and the development of the knowledge base on genetic variation and human diseases. Am J Epidemiol 2009 2.15
15 Future health applications of genomics: priorities for communication, behavioral, and social sciences research. Am J Prev Med 2010 1.98
16 Do we need genomic research for the prevention of common diseases with environmental causes? Am J Epidemiol 2005 1.92
17 STrengthening the REporting of Genetic Association studies (STREGA)--an extension of the STROBE statement. Eur J Clin Invest 2009 1.82
18 GAPscreener: an automatic tool for screening human genetic association literature in PubMed using the support vector machine technique. BMC Bioinformatics 2008 1.75
19 Application of support vector machine modeling for prediction of common diseases: the case of diabetes and pre-diabetes. BMC Med Inform Decis Mak 2010 1.66
20 Age-specific seroprevalence of HIV, hepatitis B virus, and hepatitis C virus infection among injection drug users admitted to drug treatment in 6 US cities. Am J Public Health 2002 1.61
21 An epidemiologic assessment of genomic profiling for measuring susceptibility to common diseases and targeting interventions. Genet Med 2004 1.57
22 Knowledge integration at the center of genomic medicine. Genet Med 2012 1.54
23 Strengthening the reporting of genetic association studies (STREGA): an extension of the STROBE Statement. Hum Genet 2009 1.47
24 Strengthening the reporting of Genetic RIsk Prediction Studies (GRIPS): explanation and elaboration. J Clin Epidemiol 2011 1.46
25 Does genetic testing really improve the prediction of future type 2 diabetes? PLoS Med 2006 1.43
26 Unrecognized HIV infection among patients attending sexually transmitted disease clinics. Am J Public Health 2002 1.41
27 HIV seroincidence among patients at clinics for sexually transmitted diseases in nine cities in the United States. J Acquir Immune Defic Syndr 2002 1.37
28 The emergence of epidemiology in the genomics age. Int J Epidemiol 2004 1.36
29 Genetic epidemiology with a capital E, ten years after. Genet Epidemiol 2011 1.34
30 Gene Prospector: an evidence gateway for evaluating potential susceptibility genes and interacting risk factors for human diseases. BMC Bioinformatics 2008 1.31
31 Use of the sensitive/less-sensitive (detuned) EIA strategy for targeting genetic analysis of HIV-1 to recently infected blood donors. AIDS 2002 1.27
32 Strengthening the reporting of genetic association studies (STREGA): an extension of the STROBE statement. Eur J Epidemiol 2009 1.25
33 Predictive genetic testing for type 2 diabetes. BMJ 2006 1.24
34 An open source infrastructure for managing knowledge and finding potential collaborators in a domain-specific subset of PubMed, with an example from human genome epidemiology. BMC Bioinformatics 2007 1.24
35 Beyond base pairs to bedside: a population perspective on how genomics can improve health. Am J Public Health 2011 1.21
36 Reporting of human genome epidemiology (HuGE) association studies: an empirical assessment. BMC Med Res Methodol 2008 1.17
37 Family history assessment: strategies for prevention of cardiovascular disease. Am J Prev Med 2003 1.15
38 STrengthening the REporting of Genetic Association Studies (STREGA)--an extension of the STROBE statement. Genet Epidemiol 2009 1.13
39 An automatic method to generate domain-specific investigator networks using PubMed abstracts. BMC Med Inform Decis Mak 2007 1.11
40 STrengthening the REporting of Genetic Association studies (STREGA): an extension of the STROBE Statement. Ann Intern Med 2009 1.11
41 Family history of heart disease and cardiovascular disease risk-reducing behaviors. Genet Med 2004 1.10
42 GWAS Integrator: a bioinformatics tool to explore human genetic associations reported in published genome-wide association studies. Eur J Hum Genet 2011 1.08
43 The human genome project is complete. How do we develop a handle for the pump? Am J Epidemiol 2003 1.07
44 Will genomics widen or help heal the schism between medicine and public health? Am J Prev Med 2007 1.06
45 Systems-based candidate genes for human response to influenza infection. Infect Genet Evol 2009 1.04
46 Turning the pump handle: evolving methods for integrating the evidence on gene-disease association. Am J Epidemiol 2007 1.01
47 Genome-wide association studies in pharmacogenomics: untapped potential for translation. Genome Med 2009 0.98
48 Strengthening the reporting of genetic risk prediction studies (GRIPS): explanation and elaboration. Eur J Epidemiol 2011 0.94
49 The continued need to synthesize the results of genetic associations across multiple studies. Genet Med 2008 0.93
50 The need for genetic variant naming standards in published abstracts of human genetic association studies. BMC Res Notes 2009 0.87
51 Barriers to successful dietary control among pregnant women with phenylketonuria. Genet Med 2002 0.87
52 Steroid 5-{alpha}-reductase Type 2 (SRD5a2) gene polymorphisms and risk of prostate cancer: a HuGE review. Am J Epidemiol 2009 0.85
53 Reporting of systematic reviews: the challenge of genetic association studies. PLoS Med 2007 0.85
54 Strengthening the reporting of genetic risk prediction studies (GRIPS): explanation and elaboration. Eur J Clin Invest 2011 0.85
55 Is there a need for PGxceptionalism? Genet Med 2011 0.84
56 The epidemiologic approach to pharmacogenomics. Am J Pharmacogenomics 2005 0.83
57 Make it HuGE: human genome epidemiology reviews, population health, and the IJE. Int J Epidemiol 2006 0.83
58 Public knowledge regarding the role of genetic susceptibility to environmentally induced health conditions. Community Genet 2003 0.83
59 HuGE Watch: tracking trends and patterns of published studies of genetic association and human genome epidemiology in near-real time. Eur J Hum Genet 2008 0.82
60 Five genetic variants associated with prostate cancer. N Engl J Med 2008 0.81
61 Trends in population-based studies of human genetics in infectious diseases. PLoS One 2012 0.81
62 Strengthening the reporting of genetic risk prediction studies (GRIPS): explanation and elaboration. Eur J Hum Genet 2011 0.79
63 Genomics, epidemiology, and common complex diseases: let's not throw out the baby with the bathwater! Int J Epidemiol 2006 0.77
64 Genomics and public health research. JAMA 2007 0.77
65 Editorial: Updated guidance on human genome epidemiology (HuGE) reviews and meta-analyses of genetic associations. Am J Epidemiol 2014 0.77
66 Human genomics and preparedness for infectious threats. Genome Med 2009 0.77
67 FDA workshop on emerging infectious diseases: evaluating emerging infectious diseases (EIDs) for transfusion safety. Transfusion 2011 0.76
68 Intention to analyze in pharmacogenomics studies. Cancer Epidemiol Biomarkers Prev 2008 0.76
69 Expanded publishing model for genetic association studies. Cancer Epidemiol Biomarkers Prev 2006 0.75
70 Dermatology and the human genome: an epidemiologic approach. Arch Dermatol 2007 0.75
71 Polymorphisms of adrenergic receptors and the risk of heart failure. N Engl J Med 2003 0.75
72 Building a knowledge base on genetic variation and cancer risk through field synopses. J Natl Cancer Inst 2008 0.75
73 Research priorities for public health sciences in the postgenomic era. Genet Med 2003 0.75